66
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Chronic cutaneous lupus erythematosus induced by 5-fluorouracil

Pages 917-918 | Received 25 Jun 2020, Accepted 06 Jul 2020, Published online: 17 Jul 2020

References

  • Borucki R, Werth VP. Cutaneous lupus erythematosus induced by drugs-novel insights. Expert Rev Clin Pharmacol. 2020;13:35–42.
  • Callen JP. Drug-induced subacute cutaneous lupus erythematosus. Lupus. 2010;19:1107–1111.
  • Cohen PR. Discoid lupus erythematosus lesions associated with systemic fluorouracil agents: a case report and review. Cureus. 2020;12(4):e7828.
  • Fernandes NF, Rosenbach M, Elenitsas R, et al. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy. Arch Dermatol. 2009;145:340–341.
  • Almagro BM, Steyls MC, Navarro NL, et al. Occurrence of subacute cutaneous lupus erythematosus after treatment with systemic fluorouracil. J Clin Oncol. 2011;29:e613–e615.
  • Adachi A, Nagai H, Horikawa T. Anti-SSA/Ro antibody as a risk factor for fluorouracil-induced drug eruptions showing acral erythema and discoid-lupus-erythematosus-like lesions. Dermatology. 2007;214:85–88.
  • Merlin F, Prochilo T, Kildani B, et al. Discoid lupus erythematosus (DLE)-like lesions induced by capecitabine. Int J Colorectal Dis. 2008;23:715–716.
  • Yoshimasu T, Hiroi A, Uede K, et al. Discoid lupus erythematosus (DLE)-like lesion induced by uracil-tegafur (UFT). Eur J Dermatol. 2001;11:54–57.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.